| Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: A multicentre retrospective cohort study The Lancet Infectious Diseases 16 (5), 565-575, 2016 | 296 | 2016 |
| HIV‐1 genetic variability and clinical implications MM Santoro, CF Perno International Scholarly Research Notices 2013 (1), 481314, 2013 | 235 | 2013 |
| Comet assay and micronucleus test in circulating erythrocytes of Cyprinus carpio specimens exposed in situ to lake waters treated with disinfectants for potabilization A Buschini, A Martino, B Gustavino, M Monfrinotti, P Poli, C Rossi, ... Mutation Research/Genetic Toxicology and Environmental Mutagenesis 557 (2 …, 2004 | 188 | 2004 |
| Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. HG Granich R, Gupta S, Suthar AB, Smyth C, Hoos D, Vitoria M, Simao M ... Curr HIV Res 9 (6), 446-69, 2011 | 112 | 2011 |
| Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses A Artese, V Svicher, G Costa, R Salpini, VC Di Maio, M Alkhatib, ... Drug Resistance Updates 53, 100721, 2020 | 101 | 2020 |
| Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors V Svicher, T Sing, MM Santoro, F Forbici, F Rodríguez-Barrios, A Bertoli, ... Journal of virology 80 (14), 7186-7198, 2006 | 99 | 2006 |
| Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to … F Ceccherini-Silberstein, V Svicher, T Sing, A Artese, MM Santoro, ... Journal of virology 81 (20), 11507-11519, 2007 | 85 | 2007 |
| Reliability and clinical relevance of the HIV-1 drug resistance test in patients with low viremia levels MM Santoro, L Fabeni, D Armenia, C Alteri, D Di Pinto, F Forbici, A Bertoli, ... Clinical infectious diseases 58 (8), 1156-1164, 2014 | 84 | 2014 |
| Novel human immunodeficiency virus type 1 protease mutations potentially involved in resistance to protease inhibitors V Svicher, F Ceccherini-Silberstein, F Erba, M Santoro, C Gori, ... Antimicrobial agents and chemotherapy 49 (5), 2015-2025, 2005 | 80 | 2005 |
| Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort A Mondi, A Cozzi‐Lepri, A Tavelli, S Rusconi, F Vichi, ... African Journal of Reproduction and Gynaecological Endoscopy 22 (1), 2019 | 69 | 2019 |
| High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations F Ceccherini-Silberstein, F Gago, M Santoro, C Gori, V Svicher, ... Journal of virology 79 (16), 10718-10729, 2005 | 67 | 2005 |
| Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 A Perfetti, S Greco, R Cardani, B Fossati, G Cuomo, R Valaperta, ... Scientific reports 6 (1), 38174, 2016 | 65 | 2016 |
| Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of “test and treat” J Fokam, SM Sosso, B Yagai, SC Billong, RE Djubgang Mbadie, ... AIDS research and therapy 16, 1-8, 2019 | 56 | 2019 |
| Update on SARS-CoV-2 omicron variant of concern and its peculiar mutational profile M Alkhatib, R Salpini, L Carioti, FA Ambrosio, S D’Anna, L Duca, G Costa, ... Microbiology spectrum 10 (2), e02732-21, 2022 | 53 | 2022 |
| Drug resistance among drug-naive and first-line antiretroviral treatment-failing children in Cameroon J Fokam, R Salpini, MM Santoro, V Cento, CF Perno, V Colizzi, ... The Pediatric infectious disease journal 30 (12), 1062-1068, 2011 | 53 | 2011 |
| Population dynamics of HIV-1 subtype B in a cohort of men-having-sex-with-men in Rome, Italy G Zehender, E Ebranati, A Lai, MM Santoro, C Alteri, M Giuliani, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (2), 156-160, 2010 | 51 | 2010 |
| Impact of pre-therapy viral load on virological response to modern first-line HAART MM Santoro, D Armenia, C Alteri, P Flandre, A Calcagno, M Santoro, ... Antiviral therapy 18 (7), 867-876, 2013 | 48 | 2013 |
| Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon J Fokam, R Salpini, MM Santoro, V Cento, R D’Arrigo, C Gori, CF Perno, ... Archives of virology 156, 1235-1243, 2011 | 46 | 2011 |
| Mutational correlates of virological failure in individuals receiving a WHO-recommended tenofovir-containing first-line regimen: an international collaboration SY Rhee, V Varghese, SP Holmes, GU Van Zyl, K Steegen, MA Boyd, ... EBioMedicine 18, 225-235, 2017 | 45 | 2017 |
| Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens V Svicher, C Alteri, A Artese, F Forbici, MM Santoro, D Schols, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (3), 336-344, 2010 | 45 | 2010 |
Carlo Federico PernoUniversità di MilanoVerified email at uniroma2.it